Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ardelyx - 11 Year Stock Price History | ARDX

Historical daily share price chart and data for Ardelyx since 2014 adjusted for splits and dividends. The latest closing stock price for Ardelyx as of July 24, 2025 is 4.36.
  • The all-time high Ardelyx stock closing price was 32.89 on December 03, 2014.
  • The Ardelyx 52-week high stock price is 7.18, which is 64.7% above the current share price.
  • The Ardelyx 52-week low stock price is 3.21, which is 26.4% below the current share price.
  • The average Ardelyx stock price for the last 52 weeks is 5.14.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ardelyx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.6988 5.1200 6.4200 3.2800 4.3600 -14.00%
2024 6.7301 6.0500 9.7400 4.5000 5.0700 -18.23%
2023 3.9665 2.6800 6.6400 2.6800 6.2000 117.54%
2022 1.0682 1.1800 2.8500 0.5101 2.8500 159.09%
2021 4.4896 6.4700 8.9800 0.8621 1.1000 -83.00%
2020 6.4180 7.3500 8.7900 4.3500 6.4700 -13.79%
2019 3.8078 2.0000 8.2900 1.8800 7.5050 319.27%
2018 4.4835 7.0000 7.9000 1.6600 1.7900 -72.88%
2017 8.1894 14.5500 14.9500 4.2750 6.6000 -53.52%
2016 10.6670 17.2200 17.2200 6.4800 14.2000 -21.63%
2015 17.1557 20.2600 27.4400 8.3200 18.1200 -4.08%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.050B $0.334B
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.235B 30.10
Zoetis (ZTS) United States $68.317B 25.49
Daiichi Sankyo, - (DSNKY) Japan $47.094B 24.14
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
BeOne Medicines - (ONC) Cayman Islands $32.313B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.352B 0.00
Summit Therapeutics (SMMT) United States $20.802B 0.00
Merck (MKKGY) Germany $17.312B 12.69
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.785B 12.19
Neurocrine Biosciences (NBIX) United States $13.228B 45.31
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $10.869B 0.00
Stevanato Group S.p.A (STVN) Italy $7.695B 47.06
Corcept Therapeutics (CORT) United States $7.252B 58.96
Madrigal Pharmaceuticals (MDGL) United States $6.811B 0.00
Grifols, S.A (GRFS) Spain $6.772B 0.00
Ionis Pharmaceuticals (IONS) United States $6.745B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.947B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.407B 0.00
Hypermarcas (HYPMY) Brazil $3.066B 20.17
Crinetics Pharmaceuticals (CRNX) United States $2.901B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.692B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.631B 9.22
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.529B 13.68
Centessa Pharmaceuticals (CNTA) United Kingdom $2.079B 0.00
Ocular Therapeutix (OCUL) United States $1.905B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.768B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.357B 0.00
Harrow (HROW) United States $1.356B 0.00
Guardian Pharmacy Services (GRDN) United States $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.242B 24.84
Enliven Therapeutics (ELVN) United States $1.097B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.071B 0.00
Dyne Therapeutics (DYN) United States $1.066B 0.00
Akebia Therapeutics (AKBA) United States $1.053B 0.00
Collegium Pharmaceutical (COLL) United States $1.041B 5.62
Verve Therapeutics (VERV) United States $0.989B 0.00
ProKidney (PROK) United States $0.942B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.748B 0.00
Xencor (XNCR) United States $0.681B 0.00
USANA Health Sciences (USNA) United States $0.660B 13.27
Relay Therapeutics (RLAY) United States $0.650B 0.00
Zevra Therapeutics (ZVRA) United States $0.644B 0.00
Organogenesis (ORGO) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
Theravance Biopharma (TBPH) United States $0.565B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.531B 13.48
Siga Technologies (SIGA) United States $0.512B 10.69
Tourmaline Bio (TRML) United States $0.486B 0.00
Savara (SVRA) United States $0.430B 0.00
Aquestive Therapeutics (AQST) United States $0.423B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 10.18
Altimmune (ALT) United States $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.331B 0.00
AleAnna (ANNA) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
Heron Therapeutics (HRTX) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.273B 0.00
Esperion Therapeutics (ESPR) United States $0.264B 0.00
OmniAb (OABI) United States $0.263B 0.00
Larimar Therapeutics (LRMR) United States $0.241B 0.00
MediWound (MDWD) Israel $0.227B 0.00
4D Molecular Therapeutics (FDMT) United States $0.218B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Journey Medical (DERM) United States $0.172B 0.00
Liminatus Pharma (LIMN) United States $0.168B 0.00
Avita Medical (RCEL) United States $0.165B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Korro Bio (KRRO) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.147B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Cassava Sciences (SAVA) United States $0.130B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Champions Oncology (CSBR) United States $0.107B 24.22
Nutriband (NTRB) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.076B 0.00
Rafael Holdings (RFL) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 39.56
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Plus Therapeutics (PSTV) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.44
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.91
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00